Literature DB >> 21480152

[Transcranial magnetic stimulation for psychogenic tremor - a pilot study].

M Dafotakis1, M Ameli, F Vitinius, R Weber, C Albus, G R Fink, D A Nowak.   

Abstract

Psychogenic tremor is the most common psychogenic movement disorder. Its prognosis is widely held to be poor and strongly depends on the patient's insight into the psychogenicity of the syndrome. The clinical value of transcranial magnetic stimulation (TMS) for (i) establishing the diagnosis with a high level of certainty, (ii) modulating symptom severity and (iii) facilitating patients' insight into psychogenicity was tested in 11 patients with psychogenic tremor of the upper limb. After explaining the psychogenic origin of the syndrome and providing a neurobiological model, 30 TMS pulses were applied over the hand area of the primary motor cortex contralateral to the affected hand(s) at a rate of 0.2 Hz. 15 pulses were administered at intensities of 120 % and 140 % of the resting motor threshold, respectively. Kinematic motion analysis was used to document the effectiveness of the TMS procedure. All patients met the diagnostic criteria of conversion disorder. Time elapsed since symptom onset was on average 48 to 57 months. Tremor affected both hands in 8 patients, one patient had additional head tremor. The TMS procedure caused a significant reduction of tremor frequency and thus established the diagnosis of documented psychogenic tremor according to the criteria proposed by Fahn and Williams (1988) in each patient. The duration of symptom relief was transient in 7 patients, 4 patients had lasting symptom relief. The present pilot study demonstrates that TMS is a helpful tool to (i) establish the diagnosis of psychogenic hand tremor with a high level of certainty, (ii) reduce tremor intensity and (iii) facilitate the patient's insight into the psychogenic origin of the syndrome as a prerequisite to obtain adherence to psychotherapy. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2011        PMID: 21480152     DOI: 10.1055/s-0029-1246094

Source DB:  PubMed          Journal:  Fortschr Neurol Psychiatr        ISSN: 0720-4299            Impact factor:   0.752


  7 in total

Review 1.  Functional (psychogenic) movement disorders.

Authors:  Kathrin Czarnecki; Mark Hallett
Journal:  Curr Opin Neurol       Date:  2012-08       Impact factor: 5.710

Review 2.  The differential diagnosis and treatment of tremor.

Authors:  Kai Bötzel; Volker Tronnier; Thomas Gasser
Journal:  Dtsch Arztebl Int       Date:  2014-03-28       Impact factor: 5.594

Review 3.  Non-Invasive Brain Stimulation in Conversion (Functional) Weakness and Paralysis: A Systematic Review and Future Perspectives.

Authors:  Carlos Schönfeldt-Lecuona; Jean-Pascal Lefaucheur; Peter Lepping; Joachim Liepert; Bernhard J Connemann; Alexander Sartorius; Dennis A Nowak; Maximilian Gahr
Journal:  Front Neurosci       Date:  2016-03-31       Impact factor: 4.677

Review 4.  Diagnosis and therapy of functional tremor a systematic review illustrated by a case report.

Authors:  Michael Bartl; Rebekka Kewitsch; Mark Hallett; Martin Tegenthoff; Walter Paulus
Journal:  Neurol Res Pract       Date:  2020-12-03

5.  Transcranial and muscular single-pulse magnetic stimulation is efficient on motor functional neurological disorders by the feedback of induced muscle contractions - A retrospective case series.

Authors:  Mickael Bonnan
Journal:  Clin Park Relat Disord       Date:  2021-10-20

6.  Impact of Transcranial Magnetic Stimulation on Functional Movement Disorders: Cortical Modulation or a Behavioral Effect?

Authors:  Béatrice Garcin; Francine Mesrati; Cécile Hubsch; Thomas Mauras; Iulia Iliescu; Lionel Naccache; Marie Vidailhet; Emmanuel Roze; Bertrand Degos
Journal:  Front Neurol       Date:  2017-07-19       Impact factor: 4.003

Review 7.  Neurostimulation for the treatment of functional neurological disorder: A systematic review.

Authors:  Irene Gonsalvez; Primavera Spagnolo; Barbara Dworetzky; Gaston Baslet
Journal:  Epilepsy Behav Rep       Date:  2021-11-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.